Suchergebnisse - "Shiotsu, Shinsuke"

PubPharm (78)

11

Clinical Efficacy and Safety of First- or Second-Generation EGFR-TKIs after Osimertinib Resistance for EGFR Mutated Lung Cancer : A Prospective Exploratory Study

enthalten in: Targeted oncology | 2023

von Morimoto, K. | Yamada, T. | Takeda, T. | +11

12

Predictive Value of Modified Glasgow Prognostic Score and Persistent Inflammation among Patients with Non-Small Cell Lung Cancer Treated with Durvalumab Consolidation after Chemoradiotherapy : A Multicenter Retrospective Study

enthalten in: Cancers | 2023

von Tanimura, K. | Takeda, T. | Yoshimura, A. | +11

13

Clinical Efficacy and Safety of First- or Second-Generation EGFR-TKIs after Osimertinib Resistance for EGFR Mutated Lung Cancer: A Prospective Exploratory Study

enthalten in: Targeted oncology | 2023

von Morimoto, K. | Yamada, T. | Takeda, T. | +11

14

Concomitant Proton Pump Inhibitor Use With Pembrolizumab Monotherapy vs Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer

enthalten in: JAMA network open | 2023

von Kawachi, H. | Yamada, T. | Tamiya, M. | +19

CommentIn: JAMA Netw Open. 2023 Jul 3;6(7):e2322922. - PMID 37432691

15

Predictive value of p53 and AXL immunostaining for the efficacy of immune checkpoint inhibitor-based therapy after osimertinib treatment in patients with epidermal growth factor-mutant non-small cell lung cancer

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Morimoto, K. | Yamada, T. | Sawada, R. | +15

16

Efficacy and safety of immuno-chemotherapy in patients with advanced non-small-cell lung cancer harboring oncogenic mutations : a multicenter retrospective study

enthalten in: Journal of cancer research and clinical oncology | 2023

von Hata, T. | Sakaguchi, C. | Hirano, K. | +11

17

Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell Lung Cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Platinum-Etoposide Chemotherapy

enthalten in: Drugs & aging | 2023

von Morimoto, K. | Yamada, T. | Takeda, T. | +14

18

Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell Lung Cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Platinum–Etoposide Chemotherapy

enthalten in: Drugs & aging | 2023

von Morimoto, K. | Yamada, T. | Takeda, T. | +14

19

Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell Lung Cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Platinum–Etoposide Chemotherapy

enthalten in: Drugs & aging | 2023

von Morimoto, K. | Yamada, T. | Takeda, T. | +14

20

Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell Lung Cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Platinum–Etoposide Chemotherapy

enthalten in: Drugs & aging | 2023

von Morimoto, K. | Yamada, T. | Takeda, T. | +14